Evidence map›Paper›PMID 38894581›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

A Novel tsRNA, m

Xiaoling Ying, Wenyu Hu, Yapeng Huang, Yifan Lv, Ding Ji, Cong Chen, Baotong Yang, Chengcheng Zhang, Yaomin Liang, Haiqing Zhang and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. The Roles of tRNA-Derived Fragments in Cancer: Updates and Perspectives.International journal of molecular sciences · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Deciphering the secret codes in NClinical and translational medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaoling YingCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Wenyu HuCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Yapeng HuangCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Yifan LvDepartment of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510230, China.
Ding JiDepartment of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangzhou, 510080, China.
Cong ChenCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Baotong YangDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510220, China.
Chengcheng ZhangCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Yaomin LiangCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Haiqing ZhangCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Mingrui LiuCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Gang YuanPrivate Medical Service & Healthcare Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Wenqi WuDepartment of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510220, China.
Weidong JiCenter for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.ORCID 0000-0002-9002-9362

Funding

China Postdoctoral Science Foundation 2022T150751National Natural Science Foundation of China 82073047National Natural Science Foundation of China 82272995
6 · The paper itself

Abstract

Emerging evidence indicates that transfer RNA (tRNA)-derived small RNAs (tsRNAs), originated from tRNA with high abundance RNA modifications, play an important role in many complex physiological and pathological processes. However, the biological functions and regulatory mechanisms of modified tsRNAs in cancer remain poorly understood. Here, it is screened for and confirmed the presence of a novel m

Indexed as

Annexin A2Urinary Bladder NeoplasmsAnimalsCell Line, TumorDisease Models, AnimalGene Expression Regulation, NeoplasticHumansMicePhosphorylationProto-Oncogene MasRNA, TransferAnnexin A2ANXA2 protein, humanMAS1 protein, humanProto-Oncogene MasRNA, TransferANXA2Bladder cancerm7G‐3′‐tiRNA LysTTT (mtiRL)tRNA‐derived fragmentsYes1

Identifiers

PMID38894581
PMCPMC11336930

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.